Cargando…
Enhanced Affinity for 3-Amino-Chromane-Derived σ(1) Receptor Ligands
[Image: see text] The σ(1) receptor is implicated in regulating a diverse range of physiology and is a target for developing therapies for cancer, pain management, neural degradation, and COVID-19. This report describes 36 phenethylamine-containing 3-amino-chromane ligands, which bind to σ(1) with l...
Autores principales: | Porter, Matthew R., Xiao, Haiyan, Maity, Sanjay, Vail, Nora, Smith, Sylvia B., Topczewski, Joseph J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758967/ https://www.ncbi.nlm.nih.gov/pubmed/33376910 http://dx.doi.org/10.1021/acsomega.0c05117 |
Ejemplares similares
-
Structural basis for σ(1) receptor ligand recognition
por: Schmidt, Hayden R., et al.
Publicado: (2018) -
Synthesis of Aminoethyl‐Substituted Piperidine Derivatives as σ(1) Receptor Ligands with Antiproliferative Properties
por: Holtschulte, Catharina, et al.
Publicado: (2022) -
Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity
por: Torres-Gómez, Héctor, et al.
Publicado: (2021) -
Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
por: Georgiadis, Markos-Orestis, et al.
Publicado: (2017) -
Investigation of the Entry Pathway and Molecular Nature of σ1 Receptor Ligands
por: Pascarella, Gianmarco, et al.
Publicado: (2023)